investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Tumor Heterogeneity and Acquired Resistance to EGFR Inhibition

Scott Kopetz

5 Collaborator(s)

Funding source

National Cancer Institute (NIH)

Related projects

Sara Lindstroem

Quantifying and Characterizing the shared genetic contribution to common cancers

Colorectum

Eduardo Vilar-Sanchez

Discovering New Targets for Chemoprevention in Familial Adenomatous Polyposis

Colorectum

Ramesh A Shivdasani

Chromatin and transcriptional control of LGR5+ crypt base stem cells

Colorectum

Thirumala-Devi Kanneganti

NLR signaling in colitis and colorectal tumorigenesis

Colorectum

Thomas P Quinn

In vivo Metal-Free Cycloaddition Chemistry Driven Pretargeted Cancer Radiotherapy

Colorectum

Radiation Oncology

John Jessup

Embryonic Transcription Factor Function in Human Colorectal Cancer Stem Cells

Colorectum

Shrikant Anant

Novel Dual Notch/PXR Targeting for Colon Cancer Therapy

Colorectum

Catherine O'Brien

Targeting colorectal cancer-initiating cells and anti-EGFR therapeutic resistance by manipulating levels of the reactive aldehyde, 4-hydroxynonenal.

Colorectum

Thomas Ried

Colorectal Cancer Transcriptome: Effects of Genomic Instability and Aneuploidy

Colorectum

Radiation Oncology